Contract Service Directory

LSNE Contract Manufacturing





Company Headquarters

23 Commerce Drive
Bedford, NH 03110
United States

Company Description

LSNE is a trusted CDMO and the recognized leader in lyophilization and sterile manufacturing. A global network of 6 GMP facilities in the US and Europe, positions LSNE to support the pharmaceutical, biotechnology, and medical device industries with early phase clinical and commercial supply. A history of execution. A reputation for excellence.

Contract Service Directory

    Content From LSNE Contract Manufacturing

    Related Content

    • Lyophilization
      LSNE Contract Manufacturing – The Recognized Leader in Lyophilization and Sterile Manufacturing

    • Breaking News | Industry News
      Roche Completes Spark Acquisition

      Roche Completes Spark Acquisition

      Will continue to operate as an independent company within the Roche Group
      12.17.19

    • Breaking News | Collaborations & Alliances | Supply Chain
      Schreiner MediPharm, PragmatIC Form Partnership for Smart Pharma Labels

      Schreiner MediPharm, PragmatIC Form Partnership for Smart Pharma Labels

      New RFID-labels ideal for broad array of pharmaceutical products and medical devices.
      Schreiner MediPharm 12.11.19


    • Breaking News | Promotions & Moves
      Wes Wheeler to Lead UPS Healthcare and Life Sciences Unit

      Wes Wheeler to Lead UPS Healthcare and Life Sciences Unit

      Wheeler will expand UPS's HCLS services.
      12.05.19

    • Industrial Equipment Auctions and Liquidations

    • AAPS Exhibitor List

      ...
      10.29.19


    • Adare Pharmaceuticals

      Adare Pharmaceuticals

      Adare Pharmaceuticals is a global specialty CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms.
      10.25.19

    • Adare Pharmaceuticals

      Adare Pharmaceuticals

      Adare Pharmaceuticals is a global specialty CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms.
      10.24.19

    • Breaking News | Industry News | Regulatory Affairs
      LSNE

      LSNE's Spain Site Gets FDA Approval

      LSNE-León is the fourth facility to gain commercial approval
      10.04.19



    • Breaking News | Cold Chain Management | Industry News | Packaging & Tracking
      LSNE Expands Controlled Temperature Storage Services

      LSNE Expands Controlled Temperature Storage Services

      Adds increased validated storage at Bedford site
      07.31.19

    • cGMP Manufacture | Industry News | Regulatory Affairs
      FDA Posts FY2020 GDUFA Fees

      FDA Posts FY2020 GDUFA Fees

      The fee for U.S. CMO FDF facilities will drop 7% next year; negotiation efforts led by PBOA
      07.25.19


    • Collaborations & Alliances | Drug Development
      Skyhawk, Genentech Enter Exclusive Multi-target RNA Alliance

      Skyhawk, Genentech Enter Exclusive Multi-target RNA Alliance

      Will leverage SkySTAR platform to discover and develop small molecule treatments for oncology and neurological disease targets
      07.16.19

    • Industry News | QA/QC

      WDSrx Warehouse Receives VAWD Accreditation

      The Pompano Beach, FL facility underwent a compliance review involving operating policies and procedures, licensure verification and facility survey
      07.09.19

    • cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News
      GSK Opens Two Mfg. Facilities in Singapore

      GSK Opens Two Mfg. Facilities in Singapore

      Invests $95 million for continuous manufacturing to shorten timelines to produce daprodustat
      07.09.19

    • Breaking News | cGMP Manufacture | Fill/Finish | Industry News
      LSNE, Selecta Biosciences Form Mfg. Pact

      LSNE, Selecta Biosciences Form Mfg. Pact

      LSNE to provide drug substance manufacturing and fill/finish services
      05.24.17

    • Breaking News | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Inspections | Lyophilization | Process Development

      LSNE Successfully Completes PAI

      Bedford facility to manufacture commercial drug for U.S. distribution
      01.13.15

    • APIs | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Industry News | Lyophilization | Parenterals

      Report Says Lyo-Market to Reach $4.8B in 2020

      Attributes growth to rapidly developing biopharma industry and increase in CMOs globally
      12.01.14